Bronchiolitis obliterans after allogeneic hematopoietic SCT: further insight—new perspectives?

@article{Ditschkowski2013BronchiolitisOA,
  title={Bronchiolitis obliterans after allogeneic hematopoietic SCT: further insight—new perspectives?},
  author={Markus Ditschkowski and Ahmet H. Elmaagacli and Michael Koldehoff and Tanja Gromke and Rudolf Trenschel and Dietrich W. Beelen},
  journal={Bone Marrow Transplantation},
  year={2013},
  volume={48},
  pages={1224-1229}
}
Bronchiolitis obliterans (BO) is a late non-infectious pulmonary complication after allogeneic hematopoietic SCT. Among 982 patients after myeloablative hematopoietic SCT between January 2000 and October 2010, 68 were diagnosed with BO according to NIH criteria. The median onset of BO was 18 months post transplant, 5-year cumulative incidence was 5.8% and 5-year mortality 41%. BO prevalence rate was 10% among all long-term surviving hematopoietic SCT recipients and 12% among chronic GVHD… CONTINUE READING
9 Citations
40 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-9 of 9 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 40 references

Similar Papers

Loading similar papers…